Résultats de la recherche
10
Tout
Rechercher les filtres
Organisation
Lungpacer Medical USA Inc.
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
24 mars 2025 07h00 HE
|
Lungpacer Medical USA Inc.
Lungpacer Medical Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience as CCO
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
10 mars 2025 07h00 HE
|
Lungpacer Medical USA Inc.
Lungpacer Medical is excited to announce approval of an Investigational Device Exemption (IDE) from the U.S. FDA for the STARI clinical study.
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
20 févr. 2025 07h00 HE
|
Lungpacer Medical USA Inc.
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
Lungpacer Medical Announces Premarket Approval for AeroPace® System
05 déc. 2024 09h00 HE
|
Lungpacer Medical USA Inc.
EXTON, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Lungpacer Medical, a neurostimulation company dedicated to developing innovative interventional therapies to free patients from mechanical ventilation...
Lungpacer Medical Announces PMA Submission for AeroPace® System
04 sept. 2024 09h00 HE
|
Lungpacer Medical USA Inc.
Lungpacer Medical today announced that its AeroPace System is under Food and Drug Administration (FDA) review in a premarket approval (PMA) application.
Lungpacer Medical Accelerates Pivotal Clinical Study with AeroPace™ System
14 févr. 2022 11h49 HE
|
Lungpacer Medical USA Inc.
EXTON, Pa., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Lungpacer Medical, a leading medical device innovation company, today announced the introduction of the AeroPace™ System, a next generation product,...